Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7,940 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis.
Kambhampati S, Banerjee S, Dhar K, Mehta S, Haque I, Dhar G, Majumder M, Ray G, Vanveldhuizen PJ, Banerjee SK. Kambhampati S, et al. Among authors: banerjee s, banerjee sk. Mol Cancer Ther. 2010 Mar;9(3):523-34. doi: 10.1158/1535-7163.MCT-09-0845. Epub 2010 Mar 2. Mol Cancer Ther. 2010. PMID: 20197389 Free PMC article.
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model.
Kambhampati S, Rajewski RA, Tanol M, Haque I, Das A, Banerjee S, Jha S, Burns D, Borrego-Diaz E, Van Veldhuizen PJ, Banerjee SK. Kambhampati S, et al. Among authors: banerjee s, banerjee sk. Mol Cancer Ther. 2013 Mar;12(3):255-63. doi: 10.1158/1535-7163.MCT-12-0777. Epub 2013 Jan 3. Mol Cancer Ther. 2013. PMID: 23288782 Free PMC article.
7,940 results